Use of growth hormone in low dose
US7229965B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jan 21, 2004 |
| Grant date | Jun 12, 2007 |
| Priority date | — |
| Expiry date | Feb 6, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to treatment of patients in need of increasing insulin sensitivity by administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose and the use of growth hormone or analogues thereof, preferably human growth hormone, for the manufacturing of a medicament useful for increasing insulin sensitivity in low dose therapy.The patient is preferably a normal subject, i.e. not growth hormone deficient patient and/or a non-obese patients.By low dose therapy is preferably meant less than 0.008 mg/kg/day, preferably 0.007 mg/kg/day or less, more preferably 0.005 mg/kg/day or less and most preferably 0.003 mg/kg/day or less.The therapy is preferably performed during short term treatment, preferably less than one month.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.